Glycoproteomic Analysis by LC-MS and AI/ML
Venn Vista is the first commercially available panel capable of assessing blood (serum or plasma) protein glycosylation in a site-specific manner, across more than 500 peptides and glycopeptides.
InterVenn’s AI-enabled mass spectrometry glycoproteomics platform enables researchers at academic centers and biopharmaceutical companies to assess post-translational modifications at an unprecedented scale and speed. This technology empowers them to study biology and enhance drug development efforts using an -omic dimension that more closely recapitulates the disease phenotype.
- Quantification of more than 500 glycoproteoforms in a single measurement. Protein list available upon request
- Dynamic range: 4 orders of magnitude
- High throughput analysis, suitable for large cohort studies
- Sample requirement: 10 microliters of serum/plasma
Site-specific measurement of protein glycoforms provides unique insight into protein functionality that traditional immunoassays or aptamer-based approaches cannot.Partner with us »